HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lentiviral-mediated silencing of glial fibrillary acidic protein and vimentin promotes anatomical plasticity and functional recovery after spinal cord injury.

Abstract
In spinal cord injury (SCI), absence of functional recovery and lack of spontaneous axonal regeneration are attributed, among other factors, to the formation of a glial scar that forms both physical and chemical barriers. The glial scar is composed mainly of reactive astrocytes that overexpress two intermediate filament proteins, glial fibrillary acidic protein (GFAP) and vimentin (VIM). To promote regeneration and sprouting of spared axons after spinal cord trauma and with the objective of translation to clinics, we designed an original in vivo gene transfer strategy to reduce glial scar formation after SCI, based on the RNA interference (RNAi)-mediated inhibition of GFAP and VIM. We first show that direct injection of lentiviral vectors expressing short hairpin RNA (shRNA) against GFAP and VIM in a mouse model of SCI allows efficient and specific targeting of astrocytes. We then demonstrate that the lentiviral-mediated and stable expression of shGFAP and shVIM leads to a strong reduction of astrogliosis, improves functional motor recovery, and promotes axonal regrowth and sprouting of spared axons. This study thus examplifies how the nonneuronal environment might be a major target within the lesioned central nervous system to promote axonal regeneration (and sprouting) and validates the use of lentiviral-mediated RNAi in SCI.
AuthorsMathieu Desclaux, Florence E Perrin, Anh Do-Thi, Monica Prieto-Cappellini, Minerva Gimenez Y Ribotta, Jacques Mallet, Alain Privat
JournalJournal of neuroscience research (J Neurosci Res) Vol. 93 Issue 1 Pg. 43-55 (Jan 2015) ISSN: 1097-4547 [Electronic] United States
PMID25131829 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 Wiley Periodicals, Inc.
Chemical References
  • Glial Fibrillary Acidic Protein
  • RNA, Small Interfering
  • Vimentin
  • Serotonin
Topics
  • Analysis of Variance
  • Animals
  • Astrocytes (metabolism)
  • Axons (physiology)
  • Disease Models, Animal
  • Female
  • Gene Expression Regulation (physiology)
  • Genetic Vectors (physiology)
  • Glial Fibrillary Acidic Protein (genetics, metabolism)
  • Lentivirus (genetics)
  • Locomotion (physiology)
  • Mice
  • Mice, Inbred C57BL
  • RNA, Small Interfering (genetics, metabolism)
  • Recovery of Function (physiology)
  • Serotonin (metabolism)
  • Spinal Cord Injuries (metabolism, pathology, therapy)
  • Vimentin (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: